You are here

Board of Directors

Kyle Cetrulo

Auxocell Laboratories Inc., Chief Executive Officer and co-Founder

Kyle Cetrulo has extensive experience in the stem cell industry. For fifteen years, he worked for cord blood banks that were both domestic and international, operating as both public and private banks. Cetrulo has worked in many international markets, including Brazil, Venezuela, Greece, Peru, Mexico, Russia, Spain, Portugal, Australia and Turkey. In 1998, Cetrulo became Director of the International Cord Blood Society (ICBS). During his tenure, he organized the 5th International Congress in 2002 and the 6th International Congress in 2004. These two congresses featured representatives from 23 countries. In 2006, Cetrulo served as the guest editor of an issue of the journal Stem Cell Reviews that focused on stem cells from the placenta and other pregnancy-related sources. In 2008, Cetrulo edited the book Perinatal Stem Cells, published by Wiley Press. A Second Edition of Perinatal Stem Cells came out in 2013. In 2008, Cetrulo founded the company Auxocell Laboratories Inc. (Auxocell), a leading stem cell therapeutic and regenerative medicine company located in Massachusetts. AuxoCell's primary research focus is to develop the enormous therapeutic potential of the primitive stem cells found in the Wharton's Jelly of the human umbilical cord. Cetrulo also co-founded the Perinatal Stem Cell Society in 2013, a 501(c)(3) organization dedicated to advancing perinatal stem cell research on the path toward treatment. Cetrulo graduated from the University of San Francisco in 1998, where he majored in Communications.

Gayl Chrysler, MBA

Innovative Blood Resources, Biomedical Business Development

Gayl Rogers Chrysler has over 30 years of leadership experience in strategic development and operational management of FDA regulatory-compliant businesses.  She started her medical career as a registered nurse working in blood apheresis.  Between 1982 and 2003 she worked for the North Central Blood Services of the American Red Cross. During her time at the Red Cross, she completed an MBA degree.  She increased the production capacity of the American Red Cross Apheresis Unit by 400% over a 3 year period, becoming one of the largest Apheresis Units in the U.S.  She also has worked in organ and tissue donation and has been an associate editor of the Journal of Transplant Coordination since 1991.  She created and implemented innovations to increase consented cadaver tissue donors by 300% over a one year period.  Chrysler helped create the Unrelated Bone Marrow Donor Program for the American Red Cross, a prototype for the National Marrow Donor Program.  Gayl Chrysler is best known in cord blood circles for her work as the National Director of Operations of the Cord Blood Program at the American Red Cross.  She transformed the American Red Cross Cord Blood Bank into a profitable financial operation and the fourth largest Cord Blood Bank in the U.S. after only 5 years of operations.  Chrysler joined BioE in 2006 as vice president of cellular technologies and clinical affairs.  There she was responsible for commercialization and global marketing of BioE's PrepaCyte cell separation technology. In 2012 Chrysler became the first Director of Biobanking Sales Strategy and Alliances for STEMCELL Technologies in Vancouver. Since July 2015 Chrysler heads up biomedical business development for Innovative Blood Resources.

Cherie Daly, M.D.

SLD Consultancy, Director

Dr. Cherie Daly is a qualified medical practitioner from South Africa who has clinical experience in numerous fields, with a special interest in Psychiatry. She has over a decade of experience in the stem cell industry and has worked in Africa, the Middle East, Asia, and Europe.  In the Middle East, Dr. Daly served as Executive Manager for Cryo-Save Arabia, where she was responsible for establishing and managing their cord blood laboratory in Dubai.  During her time in the Gulf Region, Dr. Daly lobbied at the governmental level and with key regional institutes to educate and introduce cord blood banking to expectant parents in a region where there was no such service.  In Singapore (2009 - 2010), Dr. Daly served as the Group Medical Affairs Manager for Cordlife, a company that is a leader in private cord blood banking in multiple Asian countries. She focused on establishing cord blood clinical trials for non-hematological indications in Asia.  In Europe (2011 - 2013), Dr. Daly worked for Cryo-Save, Europe's largest family cord blood bank, as Group Medical Affairs Consultant.  Dr. Daly then moved to Denmark and became an independent consultant in the stem cell industry. Among others, she has consulted to the Danish stem cell bank StemCare, and the Asian cord blood bank, Cordlife, in the role of Medical Affairs. She moved again to the United States in 2015, where she continues to work as an independent consultant, pushing for utilization of cord blood in clinical treatments and to establish clinical trials.  Dr. Daly has spoken at numerous regional and international medical conferences, appeared on radio and television, and speaks to prospective parents on the benefits of cord blood banking.  Her passion is to provide accurate education for both healthcare professionals and parents, and to ensure that all expectant parents have the necessary tools to enable an educated choice when it comes to their options regarding their child’s cord blood.

Deborah Hernandez, MBA

Communispace, Director of Client Services

Deborah Hernandez has extensive expertise in medical marketing. She began her career as a nurse; after graduating from Vanderbilt University with a Bachelor of Science in nursing she worked as an oncology/bone marrow transplant nurse at the Children’s Hospital of Northern California. Hernandez later joined Abbott Laboratories, first in a clinical education role, then advancing into various sales, strategic, analytical and marketing roles. She then moved to TAP Pharmaceutical Products, Inc. where Hernandez held several positions including Senior Marketing Manager for AndroGel® and Group Marketing Manager for Prevacid® Consumer and Patient Initiatives. While there, Hernandez earned her MBA in Marketing with additional studies in operations and business strategy from the Kellogg Graduate School of Management at Northwestern University. Next, Hernandez was at Biogen Idec, in Boston, as the Director of Neurology Consumer Marketing for MSActiveSource®, their service brand, Avonex®, and Tysabri®.  At the time that she joined our Board of Directors in 2007, Hernandez served as the Vice President of marketing for StemCyte, helping to launch the family banking services of a well-known public cord blood bank. Deborah Hernandez moved to PARTNERS + simons in summer 2008 as their Director of Professional Marketing. She then launched her own consulting firm in early 2010. From 2012 to 2013 Hernandez served as the Sr. Director of Marketing Communications and Public Relations for Children's Hospital of Boston. She is currently the Director of Client Services at Communispace.

Gail Moskowitz, M.D.

Consultant, Specializing in medical direction of blood and tissue banks

Dr. Moskowitz specializes in pathology and the medical leadership of blood banks.  She holds academic appointments as Lecturer in Pathology at Harvard Medical School and as Assistant Clinical Professor of Pathology at the Mount Sinai School of Medicine.  Dr. Moskowitz has held several posts directing blood banks throughout the New York area, including at the Bronx Veterans Affairs Medical Center, the New York Blood Center, and the Blood Bank and Hematology Laboratories at the Albany Medical Center.  She also served as Chairman of Pathology and Laboratory Medicine at St. Vincent's Midtown Hospital in New York.  More recently, she has served as the medical director of cord blood banks, both private and public. Dr. Moskowitz has provided healthcare consultant services in the fields of blood banking, cellular therapeutics, laboratory medicine, pharmaceutical, medical-legal and regulatory affairs, and medical informatics. Dr. Moskowitz has served on the AABB Cellular Therapies - Accreditation Program Unit.  She currently works for Merck.

Geralyn Ochab

Imagia Cybernetics, VP Sales & Business Development

Geralyn Ochab has over 20 years of leadership experience in the medical device and healthcare industries. Her strengths include corporate strategy development, building high performance teams, and growing successful businesses. She has a proven track record in general management, sales, marketing and business development. She has held progressive career positions in both public and privately held medical technology companies, including: National Sales and Marketing Manager for Emerging Markets Ultrasound for General Electric Healthcare Canada, Vice President of Sales and Marketing for Insception Lifebank, and VP Sales & Business Development for Imagia Cybernetics.

Brian Plummer

AMAG Pharmaceuticals, Manager, Public Affairs & Govt. Relations

Brian Plummer joined Cord Blood Registry in 2013, providing counsel on policy issues, as well as advocacy and legislative strategies. Prior to CBR, Brian served as the Executive Director of the Cord Blood Forum, a 501(c)(3) organization committed to advancing physician education and public awareness of cord blood medical therapies. During his tenure, Brian oversaw the nonprofit organization's expansion and managed its annual meeting, the International Cord Blood Symposium. Previously, Brian served as the State Director of Communications at the California chapter of the American Congress of Obstetricians & Gynecologists (ACOG). In that capacity, Brian directed media relations, communication strategies, and public education campaigns across the state of California on behalf of the non-profit association's 5,300 members. Key initiatives included the 2010 enactment of Assembly Bill 52, which established the Umbilical Cord Blood Collection program in the State of California. Prior to ACOG, Brian was a staff member of the Congressional Budget Office in Washington DC for 7 years. Working in the Office of Director, Brian served as a principal liaison with both chambers of Congress and was responsible for the public affairs activities of the federal, nonpartisan agency, including interaction with the media, public and private interest groups, foreign visitors, and personnel from the legislative and executive branches.

Roberto Waddington

CordVida, Chief Executive Officer

Roberto Waddington holds an economics Degree from Universidade Candido Mendes, Brazil, with further education at INSEAD (France) and at the Wharton School (USA). He started his career at the Bank of Montreal as an Investment Analyst, then moved to Pepsico where he held positions in finance and general management. Subsequently, he held positions as CFO of publicly traded companies such as Globocabo Brasil and Arisco Foods. He then held CEO positions at InVent, an early stage private equity fund in Brazil, and at CBCC, the third largest business process outsourcing company in Brazil at the time. In 2005, Roberto Waddington became CEO and Managing Partner of CordVida, the second largest stem cell bank in Brazil. In 2014 he spearheaded the formation of Associação Brasileira de Bancos de Células Tronco (ABBCT), the Brazilian Association of Stem Cell Banks.